397 related articles for article (PubMed ID: 17904683)
21. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
Lu H; Zeng L; Liang B; Shu X; Xie D
Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
[TBL] [Abstract][Full Text] [Related]
22. Association between serum retinol-binding protein 4 and small dense low-density lipoprotein cholesterol levels in young adult women.
Usui S; Ichimura M; Ikeda S; Okamoto M
Clin Chim Acta; 2009 Jan; 399(1-2):45-8. PubMed ID: 18782570
[TBL] [Abstract][Full Text] [Related]
23. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus.
Vergès B; Guiu B; Cercueil JP; Duvillard L; Robin I; Buffier P; Bouillet B; Aho S; Brindisi MC; Petit JM
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3050-7. PubMed ID: 23087360
[TBL] [Abstract][Full Text] [Related]
24. [Expression and regulation of retinol binding protein 4 mRNA in human adipose tissue in obese and type 2 diabetics].
Liu XH; Wei L; Wang LY; Zhu CY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1251-4. PubMed ID: 20646597
[TBL] [Abstract][Full Text] [Related]
25. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
[TBL] [Abstract][Full Text] [Related]
26. Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus.
Chan TF; Chen HS; Chen YC; Lee CH; Chou FH; Chen IJ; Chen SY; Jong SB; Tsai EM
Reprod Sci; 2007 Feb; 14(2):169-74. PubMed ID: 17636228
[TBL] [Abstract][Full Text] [Related]
27. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.
Jin HB; Gu ZY; Yu CH; Li YM
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522
[TBL] [Abstract][Full Text] [Related]
28. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
29. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
[TBL] [Abstract][Full Text] [Related]
30. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
[TBL] [Abstract][Full Text] [Related]
32. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
33. Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes.
Shin JY; Kim SK; Lee MY; Kim HS; Ye BI; Shin YG; Baik SK; Chung CH
Diabetes Res Clin Pract; 2011 Oct; 94(1):156-62. PubMed ID: 21862168
[TBL] [Abstract][Full Text] [Related]
34. Current status of liver disease in Korea: nonalcoholic fatty liver disease.
Park SH
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S34-9. PubMed ID: 20037278
[TBL] [Abstract][Full Text] [Related]
35. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus.
Frey SK; Spranger J; Henze A; Pfeiffer AF; Schweigert FJ; Raila J
Metabolism; 2009 Oct; 58(10):1386-92. PubMed ID: 19501859
[TBL] [Abstract][Full Text] [Related]
36. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K
Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657
[TBL] [Abstract][Full Text] [Related]
37. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
[TBL] [Abstract][Full Text] [Related]
38. Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction.
Sasaki M; Otani T; Kawakami M; Ishikawa SE
Metabolism; 2010 Apr; 59(4):527-32. PubMed ID: 19846170
[TBL] [Abstract][Full Text] [Related]
39. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
Bahr MJ; Boeker KH; Manns MP; Tietge UJ
Clin Endocrinol (Oxf); 2009 Jan; 70(1):60-5. PubMed ID: 18466349
[TBL] [Abstract][Full Text] [Related]
40. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
